Recent Articles

 
  • Fundamental & Quant Review of T2 Biosystems, Inc. (NasdaqGM:TTOO) Shares

    T2 Biosystems, Inc. (NasdaqGM:TTOO) has a Q.i. Value of 87.00000. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. The purpose of the Q.i. Value is to help identify stocks that are the most undervalued. Typically, the lower the number, the more undervalued the company tends to be. The […]

     
     
  • Imprimis Pharmaceuticals, Inc. (NasdaqCM:IMMY): Charging into the Quant Numbers

    Imprimis Pharmaceuticals, Inc. (NasdaqCM:IMMY) has a Q.i. Value of 50.00000. The purpose of the Q.i. Value is to help identify companies that are the most undervalued. Typically, the lower the value, the more undervalued the company tends to be. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield.  Piotroski […]

     
     
  • EyePoint Pharmaceuticals, Inc. (NasdaqGM:EYPT) Touches 1.160000: What Do the Quant Signals Say?

    The Price to Book ratio for EyePoint Pharmaceuticals, Inc. NasdaqGM:EYPT is 5.305620.  The Price to book ratio is the current share price of a company divided by the book value per share.  A lower price to book ratio indicates that the stock might be undervalued.  Similarly, Price to cash flow ratio is another helpful ratio in determining a company’s value.  […]

     
     
  • Does Achillion Pharmaceuticals, Inc. (NasdaqGS:ACHN) Have Solid Quant Signals? FCF Yield at -0.178092

    Checking in on some valuation rankings, Achillion Pharmaceuticals, Inc. (NasdaqGS:ACHN) has a Value Composite score of 78. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. […]

     
     
  • Is Cancer Genetics, Inc. (NasdaqCM:CGIX)’s Value Score of 78 Worth Another Look?

    Stock volatility is a percentage that indicates whether a stock is a desirable purchase.  Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year.  The Volatility 12m of Cancer Genetics, Inc. (NasdaqCM:CGIX) is 56.295600.  This is calculated by taking weekly log normal returns and standard deviation […]